Q02127 (PYRD_HUMAN) Homo sapiens (Human)
Dihydroorotate dehydrogenase (quinone), mitochondrial UniProtKBInterProSTRINGInteractive Modelling
395 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
95 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with brequinar analogue | homo-2-mer | 100 | 2×FMN; 2×ORO; 6×SO4; 2×DET; 2×JTU; | |||
| DHODH in complex with compound A0 | homo-2-mer | 100 | 6×SO4; 4×PG4; 2×FMN; 2×OG6; 6×ACT; 4×CL; 2×FJW; | |||
| DHODH in complex with Compound 15 | monomer | 100 | 1×FMN; 1×ORO; 1×A1A4M; 5×SO4; 5×ACT; 1×GOL; 7×CL; 1×PGE; 5×EDO; | |||
| DHODH in complex with Compound 8 | monomer | 100 | 1×FMN; 1×ORO; 8×ACT; 1×A1A4O; 4×SO4; 2×CL; 1×GOL; 1×EDO; 1×LDA; | |||
| HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH BREQUINAR ANALOG | monomer | 100.0 | 1×SO4; 1×ACT; 1×BRE; 1×FMN; 1×ORO; 1×DDQ; | |||
| Structure of Human dihydroorotate dehydrogenase in complex with mii-4-097 | monomer | 100 | 1×CL; 6×DDQ; 1×W7A; 1×FMN; 22×GOL; 1×ORO; 4×SO4; 7×ACT; | |||
| HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH NOVEL INHIBITOR | monomer | 100 | 1×FMN; 1×DOR; 1×SDV; 1×DDQ; 4×ACY; 3×GOL; 2×SO4; 3×CL; | |||
| HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH ANTIPROLIFERATIVE AGENT A771726 | monomer | 100.0 | 1×SO4; 1×ACT; 1×A26; 1×FMN; 1×ORO; | |||
| Crystal structure of human DHODH in complex with ferulenol | monomer | 100 | 3×SO4; 3×ACT; 1×FMN; 1×ORO; 1×9AU; | |||
| Structure of human dihydroorotate dehydrogenase in complex with ascofuranone (open-form) | monomer | 100 | 1×FMN; 1×ORO; 1×ACT; 6×SO4; 1×9BX; | |||
| The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational… | monomer | 100 | 1×SO4; 2×ACT; 1×FMN; 1×ORO; 1×R2C; 1×DDQ; | |||
| Dual binding mode of a novel series of DHODH inhibitors | monomer | 100.0 | 1×SO4; 1×ACT; 1×FMN; 1×ORO; 1×3FT; | |||
| Dual Binding Mode of a Novel Series of DHODH inhibitors | monomer | 100.0 | 4×SO4; 1×ACT; 1×FMN; 1×ORO; 1×ILB; | |||
| The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational… | monomer | 100.0 | 1×FMN; 1×ORO; 1×238; 1×DDQ; | |||
| The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational… | monomer | 100 | 1×FMN; 1×ORO; | |||
| DHODH in complex with Ligand 16 | monomer | 100 | 1×FMN; 1×ORO; 1×A1AQK; 3×ACT; 3×SO4; 1×CL; 1×GOL; | |||
| DHODH in complex with Compound 7 | monomer | 100 | 1×FMN; 1×ORO; 1×A1A4N; 3×SO4; 4×ACT; 8×CL; 10×EDO; 1×PGE; | |||
| DHODH in complex with Compound 5 | monomer | 100 | 1×FMN; 1×ORO; 1×A1A4P; 5×SO4; 2×ACT; 10×CL; 6×EDO; 2×GOL; 1×PGE; | |||
| DHODH in complex with Ligand 26 | monomer | 100 | 1×FMN; 1×ORO; 1×A1AQL; 3×SO4; 3×CL; 2×GOL; 6×ACT; | |||
| Crystal structure of human DHODH in complex with BAY 2402234 | monomer | 100.0 | 1×ORO; 1×FMN; 1×JJE; 2×SO4; 4×ACT; | |||
| Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibito… | monomer | 100.0 | 1×DUH; 2×CL; 1×FMN; 6×ACT; 1×ORO; 4×GOL; 6×PGE; | |||
| Crystal structure of human DHODH in complex with inhibitor 1289 | monomer | 100 | 6×SO4; 1×FMN; 1×ORO; 1×B5O; 1×LDA; 2×DMS; 6×ACT; 3×CL; 2×NA; | |||
| Structure of human dihydroorotate dehydrogenase in complex with 275-10-COOMe | monomer | 100 | 1×FMN; 1×ORO; 4×SO4; 5×ACT; 1×9BL; | |||
| Structure of human dihydroorotate dehydrogenase in complex with 277-11-OAc | monomer | 100 | 1×FMN; 1×ORO; 4×ACT; 3×SO4; 1×9BO; | |||
| DHODH IN COMPLEX WITH LIGAND 13 | monomer | 100 | 1×FMN; 1×ORO; 1×VU7; 4×ACT; 4×SO4; 2×GOL; 1×PGE; | |||
| Structure of human dihydroorotate dehydrogenase in complex with 287-12-OCOiPr | monomer | 100 | 1×FMN; 1×ORO; 3×ACT; 3×SO4; 1×9BU; | |||
| Structure of human dihydroorotate dehydrogenase in complex with 280-12 | monomer | 100 | 1×FMN; 1×ORO; 4×ACT; 2×SO4; 1×9BR; | |||
| DHODH IN COMPLEX WITH LIGAND 11 | monomer | 100.0 | 1×FMN; 1×ORO; 1×T6L; 4×ACT; 8×GOL; 5×SO4; | |||
| Structure of human dihydroorotate dehydrogenase in complex with 277-9-OH | monomer | 100 | 1×FMN; 1×ORO; 2×ACT; 3×SO4; 1×CHW; | |||
| Crystal structure of human Dihydroorotate Dehydrogenase in complex with the inhibitor 2-Hydroxy-N-(… | monomer | 100 | 1×FMN; 1×ORO; 1×YMH; 5×ACT; 2×SO4; | |||
| Crystal structure of human Dihydroorotate Dehydrogenase in complex with the inhibitor 2-Hydroxy-N-(… | monomer | 100 | 1×FMN; 1×ORO; 1×IEQ; 1×P6G; 1×ACT; | |||
| DHODH IN COMPLEX WITH LIGAND 19 | monomer | 100.0 | 1×FMN; 1×ORO; 1×T78; 2×SO4; 2×ACT; 1×GOL; | |||
| Crystal structure of human DHODH in complex with inhibitor 1291 | monomer | 100.0 | 4×SO4; 1×FMN; 1×ORO; 1×B5X; 1×LDA; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 9… | monomer | 100 | 1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×951; | |||
| DHODH IN COMPLEX WITH LIGAND 29 | monomer | 100.0 | 1×FMN; 1×ORO; 1×TMK; 3×ACT; 1×GOL; 1×SO4; | |||
| DHODH in complex with Ligand 10 | monomer | 100.0 | 1×FMN; 1×ORO; 1×GOL; 4×ACT; 1×A1AQM; 1×SO4; | |||
| Dihydroorotate Dehydrogenase (DHODH) crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×FMN; 1×ORO; 1×03U; 3×ACT; 2×SO4; | |||
| Crystal structure of human DHODH with OSU-03012 | monomer | 100 | 1×ORO; 1×FMN; 3×SO4; 1×M4J; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 18L compound | monomer | 100 | 1×FMN; 1×ORO; 5×SO4; 1×1KL; 2×ACT; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with compound 18T | monomer | 100 | 1×64B; 1×FMN; 1×ORO; 3×SO4; 3×ACT; | |||
| DHODH in complex with furocoumavirin | monomer | 100.0 | 1×ORO; 1×FMN; 3×GOL; 5×ACT; 1×SO4; 1×A1LYU; | |||
| Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo… | monomer | 100.0 | 1×FMN; 1×ORO; 1×HYT; 2×ACT; 3×CL; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with S416 | monomer | 100 | 1×FMN; 1×ORO; 1×EZO; | |||
| Crystal structure of human DHODH in complex with inhibitor 1243 | monomer | 100 | 1×FMN; 1×ORO; 2×SO4; 5×ACT; 1×LDA; 1×B6O; 3×NA; | |||
| Crystal structure of human DHODH in complex with inhibitor 1214 | monomer | 100 | 1×FMN; 1×ORO; 2×SO4; 5×ACT; 1×LDA; 1×B6U; 3×NA; | |||
| Crystal structure of human DHODH in complex with inhibitor 0946 | monomer | 100 | 1×FMN; 1×ORO; 3×SO4; 3×ACT; 1×LDA; 1×BVU; 3×NA; | |||
| Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo… | monomer | 100.0 | 1×FMN; 1×ORO; 1×Y9B; 2×ACT; 5×CL; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 18X at 1.86 A resolution | monomer | 100 | 1×ORO; 1×FMN; 1×18X; 4×SO4; | |||
| Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with DH03A338 | monomer | 100 | 1×FMN; 1×ORO; 1×4R5; 2×SO4; 1×ACT; | |||
| Complex of human dihydroorotate dehydrogenase with the inhibitor 221290 | monomer | 100 | 1×FMN; 1×ORO; 1×VGN; 1×DDQ; 1×ACT; 1×SO4; | |||
| Structure of DHODH in Complex with Ligand 17 | monomer | 100.0 | 1×FMN; 1×ORO; 1×A1AA2; 3×ACT; 3×SO4; 4×GOL; | |||
| Quaternary Complex of human dihydroorotate dehydrogenase (DHODH) with flavin mononucleotide (FMN), … | monomer | 100 | 1×R4P; 2×DET; 2×DDQ; 1×CL; 3×NA; 1×FMN; 1×ORO; 3×ACT; 6×GOL; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with Piperine | monomer | 100.0 | 1×ORO; 1×FMN; 1×AYR; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 057 | monomer | 100 | 1×FMN; 1×ORO; 1×JS3; 7×SO4; 5×ACY; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 066 | monomer | 100 | 1×FMN; 1×ORO; 6×SO4; 1×JTT; 3×ACT; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A312 | monomer | 100 | 1×FMN; 1×ORO; 1×3X2; 1×SO4; 4×ACT; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 072 | monomer | 100 | 1×FMN; 1×ORO; 7×SO4; 2×ACT; 1×JTS; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A356 | monomer | 100 | 1×FMN; 1×ORO; 1×3RV; 11×SO4; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A367 | monomer | 100 | 1×FMN; 1×ORO; 1×3V1; 2×SO4; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A347 | monomer | 100 | 1×FMN; 1×ORO; 6×SO4; 1×3RY; | |||
| Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with 7GF | monomer | 100 | 1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×7GF; | |||
| Human dihydroorotate dehydrogenase bound to 4-quinoline carboxylic acid inhibitor 43 | monomer | 100.0 | 1×FMN; 1×ORO; 1×F54; 1×ZWI; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with No.33 compound | monomer | 100 | 1×52Y; 1×FMN; 1×ORO; 10×SO4; | |||
| Dual binding mode of a novel series of DHODH inhibitors | monomer | 100 | 2×ACT; 4×SO4; 1×FMN; 1×ORO; 1×ILC; | |||
| Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2 | monomer | 100.0 | 1×ORO; 1×FMN; 1×SO4; 2×ACT; 1×CIH; | |||
| Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 3 | monomer | 100.0 | 1×FMN; 1×ORO; 1×SO4; 2×ACY; 1×CJH; | |||
| Crystal Structure of Human Dihydroorotate Dehydrogenase (DHODH) with Amino-Benzoic Acid Inhibitor 1… | monomer | 100.0 | 1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×1X5; | |||
| Dual binding mode of a novel series of DHODH inhibitors | monomer | 100 | 1×ACT; 5×SO4; 1×FMN; 1×ORO; 1×ILF; | |||
| Human dihydroorotate dehydrogenase bound to a novel inhibitor | monomer | 100.0 | 1×201; 1×FMN; 1×ORO; | |||
| Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4 | monomer | 100.0 | 1×ORO; 1×FMN; 1×MDY; | |||
| Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 1 | monomer | 100.0 | 1×FMN; 1×ORO; 1×BCE; 2×ACY; 1×SO4; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 6… | monomer | 100 | 1×SO4; 1×FMN; 1×DOR; 1×DET; 1×6X1; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A016 | monomer | 100 | 1×FMN; 1×ORO; 1×DET; 9×SO4; 1×4JG; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH01B0033 | monomer | 100 | 1×FMN; 1×ORO; 10×SO4; 1×B3B; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A313 | monomer | 100 | 1×FMN; 1×ORO; 5×SO4; 1×ACT; 1×3XS; | |||
| High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carb… | monomer | 100.0 | 1×FMN; 1×ORO; 1×1EA; 1×ZWI; 2×GOL; | |||
| Crystal structure of human DHODH with 18F | monomer | 100 | 1×7L7; 1×FMN; 1×ORO; 2×SO4; 4×ACT; | |||
| Crystal structure of human DHODH in complex with inhibitor 1223 | monomer | 100 | 1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×LDA; 1×BVO; | |||
| Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5 | monomer | 100.0 | 1×FMN; 1×ORO; 1×MD7; 1×SO4; | |||
| Crystal structure of human DHODH in complex with inhibitor 0944 | monomer | 100 | 1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×B6R; 1×LDA; | |||
| HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH CLASS III HISTONE DEACETYLASE INHIBITOR | monomer | 100 | 1×FMN; 1×DOR; 4×ACY; 1×GOL; 5×SO4; 1×CL; 1×DDQ; 1×F1W; | |||
| dual binding modes of a novel series of DHODH inhibitors | monomer | 100.0 | 2×SO4; 3×ACT; 1×FMN; 1×ORO; 1×ILH; | |||
| Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo… | monomer | 100.0 | 1×FMN; 1×ORO; 1×U91; 2×ACT; 3×CL; | |||
| Structure of DHODH in Complex with Fragment 2 | monomer | 100 | 1×FMN; 1×ORO; 1×A1AA1; 2×SO4; 4×ACT; 2×CL; | |||
| Crystal structure of human DHODH with TAK-632 | monomer | 100 | 1×ORO; 1×FMN; 1×PO4; 1×1SU; | |||
| High resolution crystal structure of human dihydroorotate dehydrogenase bound with DSM338 (N-[3,5-d… | monomer | 100.0 | 1×FMN; 1×ORO; 1×2V6; 2×ACY; 1×GOL; 2×NA; 1×SO4; | |||
| Crystal structure of human dihydroorotate dehydrogenase with ML390 | monomer | 100.0 | 1×FNR; 1×ORO; 1×MLJ; 2×SO4; 3×ACT; 2×CL; 1×GOL; | |||
| Human dihydroorotate dehydrogenase bound to napthyridine inhibitor 46 | monomer | 100.0 | 1×FMN; 1×ORO; 1×F51; 1×GOL; 1×SO4; 1×ZWI; | |||
| Crystal structure of human dihydroorotate dehydrogenase at 1.7 A resolution | monomer | 100 | 1×FNR; 1×ORO; 1×CE9; 2×SO4; 3×ACT; 3×CL; 1×GOL; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 7… | monomer | 100 | 1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×7Z5; | |||
| Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor | monomer | 100.0 | 1×FMN; 1×ORO; 2×SO4; 1×KFZ; 2×ACT; 1×CL; | |||
| Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor | monomer | 100.0 | 1×FMN; 1×ORO; 2×SO4; 1×CL; 1×AVQ; 2×ACT; | |||
| Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A048 | monomer | 100 | 1×FMN; 1×ORO; 1×3SH; | |||
| Human DHODH bound to inhibitor IPP/CNRS-A017 | monomer | 100 | 1×FMN; 1×ORO; 1×SO4; 1×M0B; | |||
| N-terminal microdomain of 34-mers from HsDHODH - N-t(DH) | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3u2o.1.A | monomer | 0.92 | 1×FMN; 1×ORO; 1×03U; | 100.00 | ||